Literature DB >> 19940042

Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice.

Zuyun Wang1, Lei Zhou, Zhizhen Qi, Qingwen Zhang, Ruixia Dai, Yonghai Yang, Baizhong Cui, Hu Wang, Ruifu Yang, Xiaoyi Wang.   

Abstract

Long-term protection and antibody response for the subunit vaccine F1-rV270 were determined by using the mouse model. Antibodies to F1 and rV270 were still detectable over a period of 518 days. The complete protection against lethal challenge of Yersinia pestis could be achieved up to day 518 after primary immunization.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19940042      PMCID： PMC2812077          DOI： 10.1128/CVI.00305-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  18 in total

1.  Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains.

Authors:  S M Jones; F Day; A J Stagg; E D Williamson
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

2.  Plague: from natural disease to bioterrorism.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

3.  A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.

Authors:  E D Williamson; S M Eley; A J Stagg; M Green; P Russell; R W Titball
Journal:  Vaccine       Date:  1997-07       Impact factor: 3.641

4.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Authors:  E D Williamson; P M Vesey; K J Gillhespy; S M Eley; M Green; R W Titball
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 6.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.

Authors:  Margaret Morton; Helen S Garmory; Stuart D Perkins; Aisling M O'Dowd; Kate F Griffin; Arthur K Turner; Alice M Bennett; Richard W Titball
Journal:  Vaccine       Date:  2004-06-30       Impact factor: 3.641

8.  Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.

Authors:  Zhizhen Qi; Lei Zhou; Qingwen Zhang; Lingling Ren; Ruixia Dai; Benchuan Wu; Tang Wang; Ziwen Zhu; Yonghai Yang; Baizhong Cui; Zuyun Wang; Hu Wang; Yefeng Qiu; Zhaobiao Guo; Ruifu Yang; Xiaoyi Wang
Journal:  Vaccine       Date:  2009-03-09       Impact factor: 3.641

9.  Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice.

Authors:  G W Anderson; D G Heath; C R Bolt; S L Welkos; A M Friedlander
Journal:  Am J Trop Med Hyg       Date:  1998-06       Impact factor: 2.345

10.  Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens.

Authors:  Audrey Glynn; Lucy C Freytag; John D Clements
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641
View more
  9 in total

1.  Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.

Authors:  Zhizhen Qi; Haihong Zhao; Qingwen Zhang; Yujing Bi; Lingling Ren; Xuecan Zhang; Hanqing Yang; Xiaoyan Yang; Qiong Wang; Cunxiang Li; Jiyuan Zhou; Youquan Xin; Yonghai Yang; Huiying Yang; Zongmin Du; Yafang Tan; Yanping Han; Yajun Song; Lei Zhou; Pingping Zhang; Yujun Cui; Yanfeng Yan; Dongsheng Zhou; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

2.  Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.

Authors:  Bei Li; Chunhong Du; Lei Zhou; Yujing Bi; Xiaoyi Wang; Li Wen; Zhaobiao Guo; Zhizhong Song; Ruifu Yang
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

Review 3.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Authors:  Bethany L Tiner; Jian Sha; Duraisamy Ponnusamy; Wallace B Baze; Eric C Fitts; Vsevolod L Popov; Christina J van Lier; Tatiana E Erova; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

Review 5.  Plague vaccines: current developments and future perspectives.

Authors:  Valentina A Feodorova; Vladimir L Motin
Journal:  Emerg Microbes Infect       Date:  2012-11-07       Impact factor: 7.163

6.  Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine-Comparison of Immunoinformatic and Immunological Approaches.

Authors:  Valentina A Feodorova; Anna M Lyapina; Maria A Khizhnyakova; Sergey S Zaitsev; Yury V Saltykov; Vladimir L Motin
Journal:  Vaccines (Basel)       Date:  2020-11-19

7.  A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.

Authors:  Paul B Kilgore; Jian Sha; Jourdan A Andersson; Vladimir L Motin; Ashok K Chopra
Journal:  NPJ Vaccines       Date:  2021-01-29       Impact factor: 7.344

8.  Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.

Authors:  Bethany L Tiner; Jian Sha; Yingzi Cong; Michelle L Kirtley; Jourdan A Andersson; Ashok K Chopra
Journal:  NPJ Vaccines       Date:  2016-10-13       Impact factor: 7.344

9.  Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.

Authors:  Paul B Kilgore; Jian Sha; Emily K Hendrix; Vladimir L Motin; Ashok K Chopra
Journal:  mBio       Date:  2021-12-07       Impact factor: 7.867
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.